160 related articles for article (PubMed ID: 25201476)
1. Prevalence and characteristics of metabolic syndrome in South-East Asian psoriatic patients: a case-control study.
Kokpol C; Aekplakorn W; Rajatanavin N
J Dermatol; 2014 Oct; 41(10):898-902. PubMed ID: 25201476
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study.
Gisondi P; Tessari G; Conti A; Piaserico S; Schianchi S; Peserico A; Giannetti A; Girolomoni G
Br J Dermatol; 2007 Jul; 157(1):68-73. PubMed ID: 17553036
[TBL] [Abstract][Full Text] [Related]
3. Metabolic syndrome in untreated patients with psoriasis: case-control study.
Damevska K; Neloska L; Gocev G; Mihova M
J Dtsch Dermatol Ges; 2013 Dec; 11(12):1169-75. PubMed ID: 24267013
[TBL] [Abstract][Full Text] [Related]
4. Metabolic syndrome in Tunisian psoriatic patients: prevalence and determinants.
Mebazaa A; El Asmi M; Zidi W; Zayani Y; Cheikh Rouhou R; El Ounifi S; Kanoun F; Mokni M; Osman AB; Feki M; Slimane H; Mebazaa A; Kaabachi N
J Eur Acad Dermatol Venereol; 2011 Jun; 25(6):705-9. PubMed ID: 21029207
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of metabolic syndrome in patients with psoriasis.
Nisa N; Qazi MA
Indian J Dermatol Venereol Leprol; 2010; 76(6):662-5. PubMed ID: 21079309
[TBL] [Abstract][Full Text] [Related]
6. Metabolic syndrome and psoriasis severity in South-East Asian patients: An investigation of potential association using current and chronological assessments.
Chularojanamontri L; Wongpraparut C; Silpa-Archa N; Chaweekulrat P
J Dermatol; 2016 Dec; 43(12):1424-1428. PubMed ID: 27511608
[TBL] [Abstract][Full Text] [Related]
7. Atheroma plaque, metabolic syndrome and inflammation in patients with psoriasis.
Arias-Santiago S; Orgaz-Molina J; Castellote-Caballero L; Arrabal-Polo MÁ; García-Rodriguez S; Perandrés-López R; Ruiz JC; Naranjo-Sintes R; Zubiaur M; Sancho J; Buendía-Eisman A
Eur J Dermatol; 2012; 22(3):337-44. PubMed ID: 22503884
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of metabolic syndrome and cardiovascular changes in patients with chronic plaque psoriasis and their correlation with disease severity: A hospital-based cross-sectional study.
Kothiwala SK; Khanna N; Tandon N; Naik N; Sharma VK; Sharma S; Sreenivas V
Indian J Dermatol Venereol Leprol; 2016; 82(5):510-8. PubMed ID: 27297282
[TBL] [Abstract][Full Text] [Related]
9. [Prevalence of metabolic syndrome in patients with psoriasis].
Espinoza Hernández CJ; Lacy Niebla RM; Soto López ME; Kresch Tronik NS; Vega-Memije ME
Gac Med Mex; 2014; 150(4):311-6. PubMed ID: 25098216
[TBL] [Abstract][Full Text] [Related]
10. Metabolic syndrome in Moroccan patients with psoriasis.
Meziane M; Kelati A; Najdi A; Berraho A; Nejjari C; Mernissi FZ
Int J Dermatol; 2016 Apr; 55(4):396-400. PubMed ID: 26712557
[TBL] [Abstract][Full Text] [Related]
11. Psoriasis and the metabolic syndrome.
Cohen AD; Gilutz H; Henkin Y; Zahger D; Shapiro J; Bonneh DY; Vardy DA
Acta Derm Venereol; 2007; 87(6):506-9. PubMed ID: 17989888
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of the metabolic syndrome in children with psoriatic disease.
Goldminz AM; Buzney CD; Kim N; Au SC; Levine DE; Wang AC; Volf EM; Yaniv SS; Kerensky TA; Bhandarkar M; Dumont NM; Lizzul PF; Loo DS; Kulig JW; Brown ME; Lopez-Benitez JM; Miller LC; Gottlieb AB
Pediatr Dermatol; 2013; 30(6):700-5. PubMed ID: 24016334
[TBL] [Abstract][Full Text] [Related]
13. Metabolic syndrome prevalence in psoriasis: a cross-sectional study in the Italian population.
Parodi A; Aste N; Calvieri C; Cantoresi F; Carlesimo M; Fabbri P; Filosa G; Galluccio A; Lisi P; Micali G; Potenza C; Richetta A; Simonacci M; Trevisan P; Valenti G; Calvieri S
Am J Clin Dermatol; 2014 Aug; 15(4):371-7. PubMed ID: 24756247
[TBL] [Abstract][Full Text] [Related]
14. The increased prevalence of non-alcoholic fatty liver disease in psoriatic patients: a study from South India.
Madanagobalane S; Anandan S
Australas J Dermatol; 2012 Aug; 53(3):190-7. PubMed ID: 22672067
[TBL] [Abstract][Full Text] [Related]
15. Association between psoriasis and the metabolic syndrome. A cross-sectional study.
Cohen AD; Sherf M; Vidavsky L; Vardy DA; Shapiro J; Meyerovitch J
Dermatology; 2008; 216(2):152-5. PubMed ID: 18216477
[TBL] [Abstract][Full Text] [Related]
16. Hyperuricemia in patients with chronic plaque psoriasis.
Gisondi P; Targher G; Cagalli A; Girolomoni G
J Am Acad Dermatol; 2014 Jan; 70(1):127-30. PubMed ID: 24183485
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular comorbidities in childhood psoriasis.
Torres T; Machado S; Mendonça D; Selores M
Eur J Dermatol; 2014; 24(2):229-35. PubMed ID: 24752043
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of atherosclerotic risk factors and the metabolic syndrome in patients with chronic inflammatory arthritis.
Mok CC; Ko GT; Ho LY; Yu KL; Chan PT; To CH
Arthritis Care Res (Hoboken); 2011 Feb; 63(2):195-202. PubMed ID: 20890981
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of metabolic syndrome in patients with psoriasis at Mostar Clinical Hospital.
Topić I; Simić D
Acta Clin Croat; 2013 Mar; 52(1):53-8. PubMed ID: 23837273
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of metabolic syndrome as per the NCEP and IDF definitions vis-a-vis severity and duration of psoriasis in a semi-urban Maharashtrian population: A case control study.
Sharma YK; Prakash N; Gupta A
Diabetes Metab Syndr; 2016; 10(2 Suppl 1):S72-6. PubMed ID: 26832843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
